Chemo-phosphoproteomic profiling with ATR inhibitors berzosertib and gartisertib uncovers new biomarkers and DNA damage response regulators https://www.biorxiv.org/content/10.1101/2023.04.03.535285v1?med=mas
Chemo-phosphoproteomic profiling with ATR inhibitors berzosertib and gartisertib uncovers new biomarkers and DNA damage response regulators https://www.biorxiv.org/content/10.1101/2023.04.03.535285v1?med=mas